Can Neuralink Stimulate the Brain? Speed and Feasibility Explored

• Neuralink's implant can, in principle, write to the brain by stimulating neurons through its electrodes, and Blindsight is designed to use that to create vision.
• Neuralink has not published stimulation speeds, settings, or human results; no Blindsight trial had launched as of October 2026.
• Blindsight received an FDA Breakthrough Device Designation in September 2024, and Elon Musk said in 2024 that it was already working in monkeys.

An implant that reads and writes

Neuralink's N1 implant has 1,024 electrodes on flexible threads (64 in early implants and 128 thinner threads in later ones), and its chips can both record neural activity and deliver small electrical pulses. Today's participants in the US, Canada, and the UK use the read function to control computers, typing at up to 40 words per minute, according to Neuralink's January 2026 update. The write function would activate targeted brain areas to create sensations.

Stimulation in research systems uses balanced electrical pulses designed to avoid damaging tissue. Neuralink has not published the stimulation settings or power figures for its implant. Neuralink reported zero serious device-related adverse events across its recording participants as of January 2026.

Blindsight

Blindsight is Neuralink's main planned use of stimulation. It would target the visual cortex to restore sight for people whose eyes or optic nerves no longer work, including some people blind from birth. The system would turn camera images into electrical patterns that produce phosphenes, or spots of light, in the brain.

The FDA granted Blindsight a Breakthrough Device Designation in September 2024. Musk has said early vision would be low resolution, like early Atari graphics, and that later versions could add infrared or ultraviolet detection. Neuralink's roadmap called for about 3,000 channels in 2026 and about 10,000 in 2027. Neuralink said Blindsight human trials would start in 2026; none had launched as of October 2026, and no site has been announced, according to its visual prosthesis page.

How fast it could write

Neuralink has not published how much information stimulation could deliver to the brain. Research with older cortical visual implants has produced simple shapes and letters, built up from a limited number of phosphenes. More electrodes would allow more points of light, but how many a person can tell apart, and how quickly, has to be measured in people.

Neuralink has not reported using stimulation in its CONVOY robotic arm study, so touch feedback through the implant remains a future possibility.

Feasibility

Decades of cortical stimulation research support the basic idea. Neuralink adds a high channel count, a surgical robot for precise placement, and a fully implanted wireless design that charges inductively. The $650 million Series E in June 2025 funds the work, and internal projections reported by Bloomberg target Blindsight approval by 2030 and 20,000 implants a year by 2031.

Elon Musk's wider plans

Musk has described stimulation uses beyond vision, such as touch for prosthetic limbs and, one day, sharing thoughts directly. None of these has been tested. Neuralink's current trials focus on paralysis, speech, and, next, blindness.

This article was first published in October 2025 and corrected in October 2026; the latest patient count is on the patient table.